AgomAb Therapeutics NV (AGMB) Form 10-K Annual Reports
AgomAb Therapeutics NV (AGMB) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AGMB
CIK: 2020932
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: C9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers Reviseurs d'Entreprises
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerDidier Delanoye
Audit LocationDiegem, Belgium
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-13 | 2026-10-13 | FORM 6-K | 0001104659-26-115567 | View SEC Doc Filr Page |
| 4 | 2026-10-09 | 2026-10-08 | PRIMARY DOCUMENT | 0001445826-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-05 | PRIMARY DOCUMENT | 0001445826-26-000013 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-06 | PRIMARY DOCUMENT | 0002119332-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-05 | PRIMARY DOCUMENT | 0002120886-26-000001 | View SEC Doc Filr Page |
| 6-K | 2026-10-01 | 2026-10-01 | FORM 6-K | 0001104659-26-112564 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | OWNERSHIP DOCUMENT | 0001104659-26-107916 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | OWNERSHIP DOCUMENT | 0001104659-26-107915 | View SEC Doc Filr Page |
| 3 | 2026-09-15 | 2026-09-11 | OWNERSHIP DOCUMENT | 0001104659-26-107914 | View SEC Doc Filr Page |
| 3 | 2026-09-15 | 2026-09-11 | OWNERSHIP DOCUMENT | 0001104659-26-107912 | View SEC Doc Filr Page |
| 6-K | 2026-09-14 | 2026-09-14 | FORM 6-K | 0001104659-26-107500 | View SEC Doc Filr Page |
| 6-K | 2026-09-11 | 2026-09-11 | FORM 6-K | 0001104659-26-107117 | View SEC Doc Filr Page |
| 6-K | 2026-08-10 | 2026-08-10 | FORM 6-K | 0001104659-26-093390 | View SEC Doc Filr Page |
| 6-K | 2026-08-06 | 2026-08-06 | 6-K | 0001104659-26-091992 | View SEC Doc Filr Page |
| 6-K | 2026-06-23 | 2026-06-23 | FORM 6-K | 0001104659-26-076819 | View SEC Doc Filr Page |
| 6-K | 2026-05-27 | 2026-05-27 | FORM 6-K | 0001104659-26-066590 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001104659-26-062718 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001172661-26-002216 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-06 | — | SCHEDULE 13G Filing | 0001193125-26-207455 | View SEC Doc Filr Page |
| 6-K | 2026-04-24 | 2026-04-24 | FORM 6-K | 0001104659-26-048615 | View SEC Doc Filr Page |
| 20-F | 2026-04-23 | 2025-12-31 | FORM 20-F | 0001104659-26-047872 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-16 | — | SCHEDULE 13G Filing | 0001213900-26-044365 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | OWNERSHIP DOCUMENT | 0001104659-26-030839 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | OWNERSHIP DOCUMENT | 0001104659-26-030843 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | OWNERSHIP DOCUMENT | 0001104659-26-030838 | View SEC Doc Filr Page |